Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-16 Sale |
2024-12-17 6:08 pm |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President 10% Owner |
3,117 | $0.36294 | $1,131 | 7,791,655 (Indirect Direct) |
View |
| 2024-09-16 Sale |
2024-09-17 7:21 pm |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President 10% Owner |
1,982 | $0.68966 | $1,367 | 7,789,824 (Indirect Direct) |
View |
| 2024-06-17 Sale |
2024-06-18 9:24 pm |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President 10% Owner |
2,134 | $1.2835 | $2,739 | 7,791,806 (Indirect Direct) |
View |
| 2024-06-04 Sale |
2024-06-06 8:35 pm |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal BioXcel Holdings Inc. BioXcel LLC CEO and President 10% Owner |
1,427,494 | $0.28381 | $405,135 | 7,731,185 (Indirect Direct) |
View |
| 2024-04-04 Sale |
2024-04-08 7:32 pm |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
5,268 | $2.624 | $13,823 | 8,655,189 (Indirect Direct) |
View |
| 2023-06-15 Sale |
2023-06-16 6:40 pm |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
60,000 | $20.86 | $1,251,727 | 688,607 (Indirect Direct) |
View |
| 2023-05-22 Sale |
2023-05-24 4:37 pm |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
6,500 | $25.79 | $167,641 | 39,294 (Indirect Direct) |
View |
| 2023-03-20 Sale |
2023-03-22 7:30 pm |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
64,500 | $18.97 | $1,223,313 | 9,302,644 (Indirect Direct) |
View |
| 2022-12-15 Sale |
2022-12-19 8:00 pm |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President 10% Owner |
60,000 | $19.69 | $1,181,498 | 9,416,707 (Indirect Direct) |
View |
| 2021-06-25 Sale |
2021-06-29 5:23 pm |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO, President and Secretary |
473,250 | $30.83 | $14,589,493 | 8,558,707 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-07-22 Option Award |
2025-04-01 6:08 pm |
N/A 2034-07-22 |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
6,250 | $0 | 6,250 (Direct) |
View |
| 2025-03-14 Exercise |
2025-03-17 6:35 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
379 | $0 | 488,122 (Direct) |
View |
| 2025-01-07 Option Award |
2025-01-10 8:03 pm |
N/A 2035-01-07 |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President 10% Owner |
660,000 | $0 | 660,000 (Direct) |
View |
| 2024-12-14 Exercise |
2024-12-17 6:08 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President 10% Owner |
6,110 | $0 | 7,791,655 (Direct) |
View |
| 2024-09-14 Exercise |
2024-09-17 7:21 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President 10% Owner |
6,109 | $0 | 7,789,824 (Direct) |
View |
| 2024-06-14 Exercise |
2024-06-18 9:24 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President 10% Owner |
6,109 | $0 | 7,791,806 (Direct) |
View |
| 2024-03-14 Exercise |
2024-04-08 7:32 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
16,610 | $0 | 8,655,189 (Direct) |
View |
| 2023-12-14 Exercise |
2023-12-18 4:55 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
2,609 | $0 | 8,604,457 (Direct) |
View |
| 2023-09-14 Exercise |
2023-09-18 4:47 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
2,610 | $0 | 57,707 (Direct) |
View |
| 2023-06-14 Exercise |
2023-06-16 6:40 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
62,609 | $0 | 688,607 (Direct) |
View |
| 2023-06-15 Exercise |
2023-06-16 6:40 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
60,000 | $0.41 | 688,607 (Direct) |
View |
| 2023-05-14 Exercise |
2023-05-16 8:33 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
15,000 | $0 | 32,894 (Direct) |
View |
| 2023-03-20 Exercise |
2023-03-22 7:30 pm |
N/A 2027-08-23 |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
60,000 | $0 | 9,302,644 (Direct) |
View |
| 2023-03-20 Exercise |
2023-03-22 7:30 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
60,000 | $0.41 | 9,302,644 (Direct) |
View |
| 2023-03-15 Option Award |
2023-03-16 6:00 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
224,000 | $0 | 8,824,457 (Direct) |
View |
| 2023-03-14 Exercise |
2023-03-16 6:00 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
10,437 | $0 | 8,824,457 (Direct) |
View |
| 2022-11-15 Ownership |
2023-02-14 4:41 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
145,549 | $0 | 8,558,707 (Indirect) |
View |
Ownership |
2023-02-14 4:41 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
0 | $0 | 8,558,707 (Indirect) |
View |
| 2022-12-15 Exercise |
2022-12-19 8:00 pm |
N/A 2027-08-23 |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President 10% Owner |
60,000 | $0 | 9,416,707 (Direct) |
View |
| 2022-12-15 Exercise |
2022-12-19 8:00 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President 10% Owner |
60,000 | $0.41 | 9,416,707 (Direct) |
View |
| 2022-05-14 Option Award |
2022-05-17 3:40 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-03-14 Option Award |
2022-03-16 4:17 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
208,750 | $0 | 208,750 (Direct) |
View |
| 2021-04-06 Ownership |
2022-02-14 5:38 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
233,227 | $0 | 8,558,707 (Indirect) |
View |
Ownership |
2022-02-14 5:38 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
0 | $0 | 8,558,707 (Indirect) |
View |
| 2021-03-25 Option Award |
2021-03-29 8:42 pm |
N/A 2031-03-25 |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO, President and Secretary |
250,000 | $0 | 250,000 (Direct) |
View |
| 2020-07-24 Ownership |
2021-02-16 5:29 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO, President and Secretary |
265,150 | $0 | 9,020,000 (Direct) |
View |
| 2020-05-26 Option Award |
2020-05-28 4:15 pm |
N/A 2030-05-25 |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO, President and Secretary 10% Owner |
250,000 | $0 | 250,000 (Direct) |
View |